Estimation of treatment effect in presence of noncompliance with early or late switching: a simulation study

References

• Branson, M., and J. Whitehead. 2002. Estimating a treatment effect in survival studies in which patients switch treatment. Statistics in Medicine 21 (17):2449–63. doi:10.1002/sim.1219.
   PubMed Web of Science ®Google Scholar
• Burton, A., D. G. Altman, P. Royston, and R. L. Holder. 2006. The design of simulation studies in medical statistics. Statistics in Medicine 25 (24):4279–92. doi:10.1002/sim.2673.
   PubMed Web of Science ®Google Scholar
• Collett, D. 2003. Modelling survival data in medical research. 2nd ed. Boca Raton, FL: Chapman and Hall.
   Google Scholar
• Efron, B., and R. Tibshirini. 1993. An introduction to the bootstrap monographs on statistics and applied probability. London: Chapman and Hall.
   Google Scholar
• Hosmer, D. W., and S. Lemeshow. 1999. Applied survival analysis: Regression modeling of time to event data. New York: John Wiley & Sons.
   Google Scholar
• Klein, J. P., and M. L. Moeschberger. 1997. Survival analysis: Techniques for censored and truncated data. New York: Springer-Verlag.
   Google Scholar
• Latimer, N. R., I. R. White, K. R. Abrams, and U. Siebert. 2019. Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Statistical Methods in Medical Research 28 (8):2475–93. doi:10.1177/0962280218780856.
   PubMed Web of Science ®Google Scholar
• Latimer, N. R., I. R. White, K. Tilling, and U. Siebert. 2020. Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding. Statistical Methods in Medical Research 29 (10):2900–18. doi:10.1177/0962280220912524.
   PubMed Web of Science ®Google Scholar
• Latimer, N. R., K. R. Abrams, P. C. Lambert, J. P. Morden, and M. J. Crowther. 2018. Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study. Statistical Methods in Medical Research 27 (3):765–84. doi:10.1177/0962280216642264.
   PubMed Web of Science ®Google Scholar
• Latimer, N. R., K. R. Abrams, P. C. Lambert, M. J. Crowther, A. J. Wailoo, J. P. Morden, R. L. Akehurst, and M. J. Campbell. 2017. Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method. Statistical Methods in Medical Research 26 (2):724–51. doi:10.1177/0962280214557578.
   PubMed Web of Science ®Google Scholar
• Lee, Y. J., J. H. Ellenberg, D. G. Hirtz, and K. B. Nelson. 1991. Analysis of clinical trials by treatment actually received: Is it really an option? Statistics in Medicine 10 (10):1595–605. doi:10.1002/sim.4780101011.
   PubMed Web of Science ®Google Scholar
• Li, L., S. Tang, and L. Jiang. 2017. On an enhanced rank-preserving structural failure time model to handle treatment switch, crossover, and dropout. Statistics in Medicine 36 (10):1532–47.
   PubMed Web of Science ®Google Scholar
• Mark, S. D., and J. M. Robins. 1993. A method for the analysis of randomized trials with compliance information – An application to the multiple risk factor intervention trial. Controlled Clinical Trials 14 (2):79–97. doi:10.1016/0197-2456(93)90012-3.
   PubMedGoogle Scholar
• Morden, J. P., P. C. Lambert, N. Latimer, K. R. Abrams, and A. J. Wailoo. 2011. Assessing methods for dealing with treatment switching in randomised controlled trials: A simulation study. BMC Medical Research Methodology 11:4. doi:10.1186/1471-2288-11-4.
   PubMed Web of Science ®Google Scholar
• Odondi, L., and R. McNamee. 2010. Performance of statistical methods for analysing survival data in the presence of non-random compliance. Statistics in Medicine 29 (29):2994–3003. doi:10.1002/sim.4070.
   PubMed Web of Science ®Google Scholar
• Peduzzi, P., J. Wittes, K. Detre, and T. Holford. 1993. Analysis as-randomized and the problem of non-adherence: An example from the Veterans Affairs Randomized Trial of Coronary Artery Bypass Surgery. Statistics in Medicine 12 (13):1185–95. doi:10.1002/sim.4780121302.
   PubMed Web of Science ®Google Scholar
• Robins, J. M., and A. A. Tsiatis. 1991. Correcting for non-compliance in randomized trials using rank preserving structural failure time models. Communications in Statistics - Theory and Methods 20 (8):2609–31. doi:10.1080/03610929108830654.
   Web of Science ®Google Scholar
• Robins, J. M., and D. M. Finkelstein. 2000. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics 56 (3):779–88. doi:10.1111/j.0006-341x.2000.00779.x.
   PubMed Web of Science ®Google Scholar
• Walker, A. S., I. R. White, and A. G. Babiker. 2004. Parametric randomization-based methods for correcting for treatment changes in the assessment of the causal effect of treatment. Statistics in Medicine 23 (4):571–90. doi:10.1002/sim.1618.
   PubMed Web of Science ®Google Scholar
• White, I. R. 2005. Uses and limitations of randomization-based efficacy estimators. Statistical Methods in Medical Research 14 (4):327–47. doi:10.1191/0962280205sm406oa.
   PubMed Web of Science ®Google Scholar
• Wu, Y., L. Zhao, Y. Hou, K. Li, and X. Zhou. 2015. Correcting for non-compliance in randomized non-inferiority trials with active and placebo control using structural models. Statistics in Medicine 34 (6):950–65. doi:10.1002/sim.6392.
   PubMed Web of Science ®Google Scholar
• Ye, C., J. Beyene, G. Browne, and L. Thabane. 2014. Estimating treatment effects in randomised controlled trials with non-compliance: A simulation study. BMJ Open 4 (6):e005362. doi:10.1136/bmjopen-2014-005362.
   PubMed Web of Science ®Google Scholar
• Zhang, J., and C. Chen. 2016. Correcting treatment effect for treatment switching in randomized oncology trials with a modified iterative parametric estimation method. Statistics in Medicine 35 (21):3690–57.
   PubMed Web of Science ®Google Scholar